Retour
Fourchette du Jour
38,24 €
40,15 €
Fourchette 52 Semaines
18,53 €
56,05 €
Volume
905 877
Moyenne 50J / 200J
43,18 €
/
32,61 €
Clôture Précédente
40,73 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -9,5 | 0,3 |
| P/B | 4,7 | 2,9 |
| ROE % | -50,7 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
77,60 €
+95.2%
Low: 33,00 €
High: 97,00 €
BPA Prévisionnel
-5,26 €
CA Est.
43 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
6,80 €
2,26 € – 16,10 €
|
1,4 B | 6 |
| FY2029 |
4,25 €
1,41 € – 10,07 €
|
1,1 B | 6 |
| FY2028 |
1,23 €
-1,96 € – 6,89 €
|
690 M | 8 |
Points Clés
Debt/Equity of 0,13 — conservative balance sheet
Negative free cash flow of -241,73M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-50,71%
ROIC-34,70%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,13
Current Ratio13,64
Interest Coverage-41,89
Valorisation
P/E Ratio
-9,47
P/B Ratio4,69
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -299,62M |
| ROE | -50,71% | ROA | -40,78% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -241,73M |
| ROIC | -34,70% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 13,64 |
| Interest Coverage | -41,89 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -9,47 | P/B Ratio | 4,69 |
| P/S Ratio | N/A | PEG Ratio | -0,16 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,84B | Enterprise Value | 2,56B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -299,62M | -152,15M | -95,99M | -89,06M | -32,61M |
| EPS (Diluted) | -4,66 | -2,75 | -2,25 | -3,35 | -2,43 |
| Gross Profit | -468 000,0 | 0,0 | 0,0 | 846 000,0 | 0,0 |
| Operating Income | -315,47M | -167,17M | -102,01M | -90,90M | -34,40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 734,73M | 655,68M | 175,55M | 131,44M | 83,75M |
| Total Liabilities | 130,21M | 78,53M | 73,86M | 54,53M | 14,16M |
| Shareholders' Equity | 604,52M | 577,16M | 101,69M | 76,91M | 69,59M |
| Total Debt | 77,31M | 54,64M | 53,71M | 31,29M | 4,92M |
| Cash & Equivalents | 354,73M | 92,65M | 45,68M | 43,46M | 79,67M |
| Current Assets | 728,88M | 651,22M | 172,02M | 125,70M | 82,54M |
| Current Liabilities | 53,46M | 25,37M | 22,30M | 25,60M | 7,69M |